Miller James Charles 4
4 · Recro Pharma, Inc. · Filed Feb 12, 2021
Insider Transaction Report
Form 4
Miller James Charles
Director
Transactions
- Exercise/Conversion
Stock Option (right to buy)
2021-02-09+20,000→ 20,000 totalExercise: $4.06Exp: 2031-02-09→ Common Stock (20,000 underlying)
Footnotes (1)
- [F1]The option vests in three equal installments on February 9, 2022, 2023 and 2024.